EMEA – FDA Good Clinical Practice Initiative
The European Medicines Agency has published a GCP initiative document outlining a process which focuses on enhanced and systematic Good Clinical Practice related information exchanges between the European Medicines Agency and the US Food and Drug Administration combined with collaboration in the conduct of Good Clinical Practice inspections of clinical trials.
Published Date: 10 February 2010